Literature DB >> 32281221

Chin augmentation with the use of cannula from a single, midline entry point: Evaluation of 50 patients.

Ali Sahan1, Nermin Karaosmanoglu2, Pınar Ozdemir Cetinkaya3.   

Abstract

BACKGROUND: A chin that is of right size, shape, and contour plays a crucial role in overall facial balance and esthetically harmonious appearance. Dermal fillers have been widely used for correcting mild to moderate chin retrusion and resorption. AIMS: The aim of this study was to share our preferential technique for chin augmentation and to evaluate our results in 50 patients.
METHODS: A total of 50 patients consisting of females who received hyaluronic acid injection for chin augmentation and rejuvenation were enrolled in the study. We have described chin augmentation technique with the use of cannula from a single, midline entry point.
RESULTS: The study included 50 female patients, and the mean age was 37.56 ± 8.84 years. The median injected filler volume for augmentation of the mental area was 2.25 mL (minimum = 1, maximum = 4 mL). Four (8%) patients had ecchymosis related to the procedure.
CONCLUSION: Chin has a profound effect on the perception of attractiveness and is an area of concern for rejuvenation of the lower third of the face. Our preferential technique allows the practitioners to increase the likelihood of a satisfactory esthetic outcomes and minimize the risks of the procedure.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  chin; dermal filler; hyaluronic acid

Mesh:

Substances:

Year:  2020        PMID: 32281221     DOI: 10.1111/jocd.13411

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN: 1473-2130            Impact factor:   2.696


  2 in total

1.  Chin Augmentation With Hyaluronic Acid: An Injection Technique Based on Anatomical Morphology.

Authors:  Bo Chen; Li Ma; Jingyi Wang
Journal:  Dermatol Surg       Date:  2022-04-25       Impact factor: 2.914

2.  Safe and Effective Chin Augmentation With the Hyaluronic Acid Injectable Filler, VYC-20L.

Authors:  Kenneth Beer; Joely Kaufman-Janette; David Bank; Brian Biesman; Steven Dayan; William Kim; Smita Chawla; Andrew Schumacher
Journal:  Dermatol Surg       Date:  2021-01-01       Impact factor: 2.914

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.